Katie Simmonds is an associate in Weil’s Mergers & Acquisitions practice and is based in New York. Ms. Simmonds assists in the representation of public and private companies in mergers, acquisitions and divestitures.
Ms. Simmonds has been part of the teams advising:
- Transaction Committee of the Board of Directors of Reynolds American Inc. in the $60.6 billion sale to British American Tobacco p.l.c. (BAT) of the 57.8% of Reynolds stock that BAT did not already own
- Sanofi in its pending $11.6 billion acquisition of Bioverativ Inc.
- Straight Path Communications Inc. in its pending $3.1 billion sale to Verizon Communications, Inc.
- Avista Healthcare Public Acquisition Corp., a SPAC sponsored by Avista Capital Holdings, in its $924 million merger with Envigo International Holdings, Inc.
Ms. Simmonds received her L.L.B. and B.Com from the University of Sydney.